ACThio1, which is devoid of the sigma-2 receptor-targeting moiety (i.e., the basic amine), is instead characterized by an enhanced activity in normal cells compared to cancer cells, thus highlighting the importance of the basic moiety for reduced toxic action. This evidence concerns the gene TMEM97 and cancer.